Oncology

Lymphoma Panel

Comprehensive Genetic Screening for Hodgkin and Non-Hodgkin Lymphomas

Leukemia-Panel FSG
The Lymphoma Panel is a targeted genetic screening designed to identify mutations and gene rearrangements associated with both Hodgkin and non-Hodgkin lymphomas. This test aids in accurate diagnosis, classification, treatment planning, and monitoring, offering personalized insights into each patient’s disease.

Conditions Detected by Lymphoma Panel

01
Hodgkin Lymphoma
02
Non-Hodgkin Lymphoma (NHL)
03
Diffuse Large B-Cell Lymphoma (DLBCL)
04
Follicular Lymphoma

Precision Medicine for Lymphoma Patients

Accurate Subtyping

Identify specific lymphoma types to guide targeted therapeutic strategies.

Informed Treatment Decisions

Tailor treatments based on the molecular profile for enhanced effectiveness.

Predictive Markers

Assess potential treatment response and disease prognosis with genetic insight.

Ongoing Monitoring

Track changes during treatment and detect recurrence or resistance early.

How It Works

Streamlined Testing for Focused Cancer Care

Sample Collection

Tissue or blood samples are collected through minimally invasive procedures.

Advanced Sequencing

Next-generation sequencing reveals gene mutations and structural variations linked to lymphoma.

Clinical Insights

Receive an expert-reviewed report to support diagnosis and clinical decision-making.

Why Choose FSG for Lymphoma Testing

01

Cutting-Edge Genomics
We utilize advanced molecular tools for accurate and reliable lymphoma profiling.

02

Oncology Expertise
Our team includes experienced hematopathologists and molecular oncologists.

03

Fast Turnaround
Get detailed results and recommendations in just a few business days.

04

Trusted Laboratory
FSG is UAE’s first certified molecular stem cell and genomics laboratory.
FAQ’s

Frequently Asked Questions!

We’re here to help. Explore answers or reach out to our team directly.
The Lymphoma Panel is a comprehensive diagnostic test used to detect and classify various types of lymphoma by analyzing genetic and molecular markers in blood or tissue samples.
This test is recommended for individuals showing symptoms such as unexplained weight loss, swollen lymph nodes, night sweats, or persistent fatigue, or for those with a family history of lymphoma.
The test is usually done using a blood sample or a biopsy of lymph node tissue. Advanced techniques like flow cytometry, immunohistochemistry, or genetic sequencing may be used for detailed analysis.
It can identify and differentiate between Hodgkin and non-Hodgkin lymphoma subtypes, as well as provide insights into the genetic profile of the cancer, which can guide personalized treatment options.
Results typically take between 5 to 10 business days, depending on the complexity of the analysis and specific tests included in the panel.

Ready to Get Started? Schedule Your Appointment

    Are You Ready? Book Appointment Now!